Molnupiravir is an oral medication that may be used to treat Covid-19, prevent serious symptoms, and shorten infections.
What is molnupiravir and how does it work?
Molnupiravir is an oral antiviral medication that is currently being explored in clinical trials as a potential treatment for Covid-19. Molnupiravir works by causing genetic copying errors in the SARS-CoV-2 virus. This ‘lethal mutagenesis’ affects the integrity of the virus and impairs its ability to replicate and spread.
What are the benefits of Molnupiravir as Covid-19 treatment?
Molnupiravir has demonstrated several benefits against Covid-19:
- Treatments may shorten the duration of infection and reduce the severity of symptoms.
- Molnupiravir may also reduce the amount of time it takes for the virus to clear the body and thus produce a negative Covid test result following infection.
- If administered within the first few days of infection, molnupiravir may prevent serious symptoms.
- In October 2021, Merck announced that molnupiravir reduced the chance of hospitalization or death by 50% in one study, as compared to study participants who took a placebo.
Request Consultation for
Molnupiravir Covid-19 Treatment
Frequently Asked Questions
Is molnupiravir FDA approved?
Is molnupiravir safe?
One stage 2 clinical trial found that molnupiravir is both effective and well-tolerated, meaning that there were few reported side effects. Fewer than 50% of study participants reported side effects in one study. The same study found that of these reports, 93% of side effects were mild.